Clinical Trial Update: Metabolic Dysregulation as Biomarker of Frailty: Role of the Mitochondrial Dysfunction

View source ↗

Summary

A clinical trial update exploring metabolic dysregulation as a biomarker of frailty, focusing on mitochondrial dysfunction in aging populations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging
• Frailty

Snippet

Sponsor: University Hospital of Ferrara | Conditions: Aging, Frailty | Status: UNKNOWN